Lewin Group Blood Products Reimbursement Study Expected This Summer
This article was originally published in The Gray Sheet
Executive Summary
An upcoming Lewin Group study commissioned by AdvaMed will identify problem areas in the way hospitals are reimbursed for blood and blood products under the Medicare inpatient prospective payment system (IPPS), the trade group says
You may also be interested in...
CMS Blood Billing Rules Lead To Inadequate Reimbursement – Lewin Report
Updated guidelines on properly billing CMS for blood products and services will soon be available to hospitals from the American Association of Blood Banks, the industry group announced Oct. 15
CMS Blood Billing Rules Lead To Inadequate Reimbursement – Lewin Report
Updated guidelines on properly billing CMS for blood products and services will soon be available to hospitals from the American Association of Blood Banks, the industry group announced Oct. 15
Future OPPS Pro-Rata Reductions Limited To 20% Under Senate Bill
A medical device industry and hospital-supported bill that sets an outer limit on the level of pro-rata reduction allowed each year under the hospital outpatient prospective payment system (OPPS) is likely to be included into a larger Medicare package later this year